8585 Picardy Avenue, Baton Rouge, LA 70809, USA
Dr. Lauren Juneja is a Board Certified Hematologist/Oncologist in Baton Rouge, LA. She is driven by the innovative and research-heavy nature of this specialty, both on a clinical level down to the molecular sciences. Furthermore, the fields of medical oncology and hematology provide her with the opportunity to take her interest in scientific details and apply them to a bigger picture involving patient care, treatment and overall patient well-being.
Fellowship: Hematology Oncology Feist-Weiller Cancer Center Shreveport, LA
Residency: Internal Medicine LSU Health Science Center Shreveport, LA
MD - 2012 LSU School of Medicine Shreveport, LA
American Board of Internal Medicine
Videos
So my name is Lauren Juneja and I’m a medical oncologist and hematologist in Baton Rouge, Louisiana. So I did my medical training at LSU in Shreveport, Louisiana, as well as my medical residency and...
Watch and ShareVideos
So let’s talk about triple negative breast cancer, which means that those three receptors that we talked about previously, those are all negative. So for triple negative breast cancer, it does tend to be a...
Watch and ShareVideos
So let’s talk about the chemotherapy that’s generally given for breast cancer. So chemotherapy, again, is not targeted treatment, but it’s what’s called cytotoxic treatment, which means that it’s going to be affecting the cells...
Watch and ShareVideos
Other common side effects with the chemotherapy we use for breast cancer are nausea, although generally patients don’t have vomiting because the medications that we provide for antinausea are very effective. In addition, sometimes patients...
Watch and ShareVideos
A lot of patients nowadays will get treatment upfront with IV chemotherapy and anti HER2 treatment. And so if that’s the case, your medical oncologist will determine exactly what treatment regimen they’re going to use....
Watch and ShareVideos
More so in the recent years, we have been treating those patients what’s called neoadjuvantly, which means that they’re going to get systemic, generally IV chemotherapy and anti HER2 treatment upfront prior to the surgery....
Watch and ShareVideos
For your HER2 medications, those are generally Pertuzumab derivative and trastuzumab derivative. And sometimes patients only need trastuzumab derivatives, but for certain cancers, your medical oncologist may use both. These medications can affect the heart,...
Watch and ShareVideos
One important thing on HER2 and I’ll also talk about in triple negative disease, but when you’re doing that upfront treatment with your IV treatments, an important question, when you get your final pathology, when...
Watch and ShareVideos
So the main things you want to think about when you’re on an endocrine therapy are, what are the side effects from endocrine therapy? So sometimes I hear patients say that they’re on their chemo...
Watch and ShareVideos
So receptors are little protein signals on the outside of the breast cancer. And what they do is they send a signal down through that cell, which allows the cancer to grow and generally grow...
Watch and Share
This doctor has not yet uploaded content to this section
This doctor has not yet uploaded content to this section
This doctor has not yet uploaded content to this section
This doctor has not yet uploaded content to this section
This doctor has not yet uploaded content to this section
8585 Picardy Avenue, Baton Rouge, LA 70809, USA
225-767-0822
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
